Why the study?
Does intravenous lidocaine suppress or terminate cardiac arrhythmias in unanesthetized patients?
Does intravenous lidocaine suppress or terminate cardiac arrhythmias in unanesthetized patients?
Intravenous lidocaine is highly effective and safe for suppressing ventricular arrhythmias but is largely ineffective for supraventricular arrhythmias.
Answers are grounded in this paper and cite their sources.
Lidocaine may selectively suppress ventricular arrhythmias; leaves open confirmation in randomized trials of unanesthetized patients.
Sixty unanesthetized patients with 74 cardiac arrhythmias received lidocaine intravenously in an average dose of 1.5 mg/kg in 30 seconds. Suppression or termination of ventricular arrhythmias occurred in more than 80% of the 33 patients whether they had an acute myocardial infarction, were receiving digitalis, or were not receiving digitalis or digitalis toxic. Only 15% (six out of 41 patients) of the supraventricular arrhythmias were affected. Minimal side effects, mainly drowsiness, appeared in 47% of the patients and lasted less than five minutes. Blood pressure changes were not significant and no hypotension or convulsions occurred. Continous infusion of lidocaine (1 to 3.5 mg/min) for up to five days, without side effects, suppressed ventricular arrhythmias in all 18 patients treated. Lidocaine appears effective in suppressing or terminating ventricular arrhythmias occurring in a variety of clinical conditions. It is only occasionally effective in atrial arrhythmias.
No takes yet. Share an insight, caveat, or question.
James I. Grossman (1968) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: